A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: during (1000)

Specialty Research Lead JD March 2022

Description
Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size o
Url
/Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-March-2022.pdf

Transnasal oesophagoscopy - patient information

Description
This factsheet explains what a transnasal oesophagoscopy is, what the procedure involves and how to prepare for it.
Url
/Media/UHS-website-2019/Patientinformation/Ear-nose-and-throat/Transnasal-oesophagoscopy-3113-PIL.pdf

Paclitaxel (7 day)

Description
Chemotherapy Protocol BLADDER CANCER PACLITAXEL (7 day) Regimen • Bladder Cancer – Paclitaxel (7 day) Indication • Treatment of locally ad
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Paclitaxel-7-day.pdf

Mitoxantrone-Prednisolone ver1.2

Description
Chemotherapy Protocol PROSTATE MITOXANTRONE-PREDNISOLONE Regimen  Prostate-Mitoxantrone-Prednisolone Indication  Castrate resistant prostate cancer  Perf
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Mitoxantrone-Prednisolone-ver1.2.pdf

Pemetrexed (maintenance)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) PEMETREXED (Maintenance) Regimen NSCLC – Pemetrexed (Maintenance) Indication Pemetrexed is rec
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pemetrexedmaintenancever11.pdf

Vinflunine

Description
Chemotherapy Protocol BLADDER Regimen VINFLUNINE • Bladder – Vinflunine Indication • Bladder cancer that has failed to respond or progressed with in t
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Vinflunine.pdf

Temsirolimus v1.1

Description
Chemotherapy Protocol RENAL CELL TEMSIROLIMUS This protocol may require funding Regimen Renal Cell - Temsirolimus Indication First li
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Temsirolimus-v1.1.pdf

Sunitinib v1.1

Description
Regimen Renal Cell - Sunitinib Indication Chemotherapy Protocol RENAL CELL SUNITINIB First line treatment of advanced or metastatic renal cell carcinoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Sunitinib-v1.1.pdf

Rituximab (8 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma as first-line m
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

Rituximab (12 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (12 weekly) Regimen Lymphoma – Rituximab (12 Weekly) Indication Non- Hodgkin’s Lymphoma as maintenan
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-12-weekly.pdf
341 to 350 of 554
Previous … 33 34 35 36 37 … Next